Maxigen Biotech Inc. - Taiwan Figures in New Taiwan dollars. 2026 2025 Revenue NT$86,139,000 NT$78,908,000 Jan-Jun Revenue NT$411,881,000 NT$386,002,000 Source: Taiwan Stock Exchange This content was automatically published based on data and/or text from the original source. For feedback, write to singaporeeditors@dowjones.com.